Abstract
Our previous study selected a promising chemopreventive agent 3,6-dihydroxyflavone (3,6-DHF) and found that 3,6-DHF significantly upregulates miR-34a and downregulates miR-21 in breast carcinogenesis, yet the upstream and downstream events of the anticancer mechanism remain unclear. The present study showed that 3,6-DHF cotreatment effectively inhibits carcinogens-induced breast carcinogenic transformation in human breast epithelial MCF10A cells. The data revealed the significant downregulation of miR-34a and upregulation of miR-21 in breast carcinogenesis, which could be mitigated by 3,6-DHF treatment. Methylation-specific PCR detections showed that 3,6-DHF inhibits the hypermethylation of the miR-34a promoter. Further studies indicated that 3,6-DHF is an effective methyltransferase (DNMT)1 inhibitor, docking to the putative cytosine pocket of the protein, and thus decreases the DNMT activity in a dose-dependent manner. Moreover, the ChIP-qPCR analysis for histone modifications showed that 3,6-DHF treatment significantly lowers the H3K9-14ac on the miR-21 promoter. In addition, our study revealed that 3,6-DHF represses the PI3K/Akt/mTOR signaling pathway in breast carcinogenesis in vitro and in vivo. Inhibition of miR-34a or o...Continue Reading
References
Jul 29, 2009·Natural Product Reports·Alan CrozierMichael N Clifford
Jan 13, 2011·Virchows Archiv : an International Journal of Pathology·Markus VogtHeiko Hermeking
Jun 2, 2011·Chinese Journal of Cancer·Lindsey E Becker Buscaglia, Yong Li
Aug 11, 2011·Recent Patents on Inflammation & Allergy Drug Discovery·Laura MarzocchellaRoberto Bei
Dec 1, 2011·Epigenomics·Kwan Yeung WongChor Sang Chim
Apr 25, 2012·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Yasmeen M Nkrumah-ElieSelina F Darling-Reed
May 12, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michelle A T HildebrandtXifeng Wu
May 24, 2012·Breast Cancer Research : BCR·Chang HuiMi Mantian
Jun 9, 2012·Carcinogenesis·Chandi Charan MandalNandini Ghosh-Choudhury
Jan 26, 2013·PloS One·Chang HuiMi Mantian
Feb 9, 2013·Carcinogenesis·Dong-Mei ZhangWen-Cai Ye
Feb 14, 2013·Carcinogenesis·Xin WangChunxu Hai
Mar 6, 2013·Antioxidants & Redox Signaling·Ann M Bode, Zigang Dong
Apr 5, 2013·PloS One·Man-Tat LauPeter C K Leung
Apr 18, 2013·International Journal of Molecular Sciences·Zachary C Dobbin, Charles N Landen
May 1, 2013·International Journal of Cancer. Journal International Du Cancer·Erika MartinelliFortunato Ciardiello
Aug 6, 2013·Nutrition and Cancer·Gordana SupicZvonko Magic
Aug 6, 2013·Nutrition and Cancer·Monika A IzanoMichelle D Holmes
Oct 11, 2013·The American Journal of Clinical Nutrition·Lilli B LinkPamela L Horn-Ross
Oct 25, 2013·Annals of Surgical Oncology·Kojiro EtoHideo Baba
Jan 25, 2014·Cell Death & Disease·W L NgY Wang
Jan 30, 2014·The Journal of Pharmacology and Experimental Therapeutics·Thae Hyun KimKi Hyung Kim
Feb 18, 2014·Genes & Development·Nobuhiro OkadaLin He
Feb 26, 2014·Biomaterials·Xiongwei DengYi Zeng
Feb 28, 2014·Molecular Microbiology·Tetsuya Chujo, Barry Scott
Apr 9, 2014·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Gong-Ling PengChun-Ping Liu
Citations
Aug 12, 2015·Chemical Biology & Drug Design·Ammad Ahmad FarooqiPierluigi Benedetti Panici
Sep 28, 2016·Cell Biology International·Danying Chen, Zuolin Wang
Mar 1, 2018·Frontiers in Pharmacology·Yunfeng FuRong Gui
Jun 28, 2016·Scientific Reports·Junli ChenMantian Mi
Sep 6, 2017·BMC Cancer·Xiaoli PengMantian Mi
Nov 30, 2019·Stem Cells International·Xiao LiangXiang Li
Apr 21, 2020·Journal of Oncology·Xiaocheng CaoJianguo Cao
Aug 30, 2018·Frontiers in Immunology·Jessica C Hargarten, Peter R Williamson
Sep 14, 2017·International Journal of Oncology·Yu-Jin LeeByoung-Mog Kwon
Apr 6, 2021·Frontiers in Endocrinology·Ximena M Bustamante-MarinDelisha A Stewart
Apr 24, 2021·Nucleic Acid Therapeutics·Nahid Arghiani, Maryam M Matin
May 1, 2021·Nutrients·Getinet M AdinewKaram F A Soliman
Sep 24, 2021·Cell Death & Disease·Yike WangJingpei Long